Latest news

• NHS to offer two new treatments for drug-resistant superbugs as part of a new subscription-style payment plan

  NHS England, the National Institute for Health and Care Excellence (NICE) and the UK Department of Health have concluded an assessment of Pfizer’s Zavicefta (ceftazidime with avibactam) and Shionogi’s ... Fetcroja can be used to treat urinary tract

• Merck preps regulatory filings for much-needed antibiotic combo

  It’s been sold in Europe by Pfizer as Zavicefta since 2016.

• Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought

  The antibiotic is sold in Europe by Pfizer under the Zavicefta brand name and got a green light from the EMA in 2016. ... Zavicefta is already approved in Europe for HABP/VABP. One of the key roles for the new product is in the treatment of infections

• Pfizer launches antibiotic resistance surveillance website

  Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn

• Pfizer launches new antibiotic Zavicefta in UK and Germany

  The European Medicines Agency (EMA) cleared Zavicefta (ceftazidime and avibactam) for the treatment of complicated Gram-negative bacterial infections requiring hospitalisation last year. ... The availability of Zavicefta is a major step forward for